Taysha Gene Therapies (TSHA) Debt Ratio (2020 - 2026)

Taysha Gene Therapies (TSHA) has 7 years of Debt Ratio data on file, last reported at 0.16 in Q1 2026.

• For the quarter ending Q1 2026, Debt Ratio fell 46.87% year-over-year to 0.16; the trailing twelve-month figure through Mar 2026 stood at 0.16 (down 46.87% YoY), and the FY2025 full-year result was 0.15, down 46.74% from the prior year.
• Debt Ratio improved to 0.16 in Q1 2026, from 0.15 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 0.47 in Q2 2023 to a low of 0.12 in Q2 2025.
• A 5-year average of 0.25 and a median of 0.24 in 2024 frame the typical range for Debt Ratio.
• Across the five-year window, Debt Ratio soared 193.69% in 2022 and plunged 59.86% in 2024, its largest moves.
• Tracing TSHA's Debt Ratio over 5 years: stood at 0.3 in 2022, then retreated by 22.0% to 0.23 in 2023, then gained by 16.84% to 0.27 in 2024, then sank by 46.74% to 0.15 in 2025, then rose by 11.69% to 0.16 in 2026.
• Business Quant data shows TSHA's Debt Ratio at 0.16 in Q1 2026, 0.15 in Q4 2025, and 0.16 in Q3 2025.